Laura Caquelin

Artiklar

Article: RESEARCH SYNTHESIS METHODS. 2024;15(6):964-977
Meta-analyses of phase I dose-finding studies: Application for the development of protein kinase inhibitors in oncology
Caquelin L; Badra P; Poulain L; Laviolle B; Ursino M; Locher C
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;152(12):2474-2484
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020
Gloy V; Schmitt AM; Dueblin P; Hirt J; Axfors C; Kuk H; Pereira TV; Locher C; Caquelin L; Walter-Claudi M; Lythgoe MP; Herbrand A; Kasenda B; Hemkens LG
Article: THERAPIE. 2022;77(2):207-217
Pharmacology and pharmacovigilance of protein kinase inhibitors
Khouri C; Mahe J; Caquelin L; Locher C; Despas F
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2021;137:241-249
Intent to share Annals of Internal Medicine's trial data was not associated with data re-use
Pellen C; Caquelin L; Bail AJ-L; Gaba J; Verin M; Moher D; Ioannidis JPA; Naudet F
Article: BMJ OPEN. 2020;10(5):e038887
Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations.
Siebert M; Gaba JF; Caquelin L; Gouraud H; Dupuy A; Moher D; Naudet F